Education
About Us
Working with TipRanks
Follow Us
BeOne Medicines (ONC)
NASDAQ:ONC
Total Valuation
BeOne Medicines has a market cap or net worth of $30.12B. The enterprise value is $291.90B.
Market Cap$30.12B
Enterprise Value$291.90B
Share Statistics
BeOne Medicines has 109,600,250 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding109,600,250
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
BeOne Medicines’s return on equity (ROE) is -0.19 and return on invested capital (ROIC) is -15.02%.
Return on Equity (ROE)-0.19
Return on Assets (ROA)-0.11
Return on Invested Capital (ROIC)-15.02%
Return on Capital Employed (ROCE)-0.15
Revenue Per Employee346.39K
Profits Per Employee-58.62K
Employee Count11,000
Asset Turnover0.64
Inventory Turnover1.20
Valuation Ratios
The current PE Ratio of BeOne Medicines is -30.16. BeOne Medicines’s PEG ratio is -5.38.
PE Ratio-30.16
PS Ratio0.00
PB Ratio67.27
Price to Fair Value5.84
Price to FCF-150.01
Price to Operating Cash Flow-197.03
PEG Ratio-5.38
Income Statement
In the last 12 months, BeOne Medicines had revenue of 3.81B and earned -644.79M in profits. Earnings per share was -6.12.
Revenue3.81B
Gross Profit3.22B
Operating Income-568.20M
Pretax Income-533.00M
Net Income-644.79M
EBITDA-396.44M
Earnings Per Share (EPS)-6.12
Cash Flow
In the last 12 months, operating cash flow was 212.02M and capital expenditures -452.49M, giving a free cash flow of -240.47M billion.
Operating Cash Flow212.02M
Free Cash Flow-240.47M
Free Cash Flow per Share-2.19
Dividends & Yields
BeOne Medicines pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.00
52-Week Price Change69.89%
50-Day Moving Average247.69
200-Day Moving Average227.29
Relative Strength Index (RSI)53.80
Average Volume (3m)321.11K
Important Dates
BeOne Medicines upcoming earnings date is Aug 30, 2025, TBA (Confirmed).
Last Earnings DateMay 7, 2025
Next Earnings DateAug 30, 2025
Ex-Dividend Date―
Financial Position
BeOne Medicines as a current ratio of 1.80, with Debt / Equity ratio of 20.33%
Current Ratio1.80
Quick Ratio1.58
Debt to Market Cap0.05
Net Debt to EBITDA3.90
Interest Coverage Ratio0.00
Taxes
In the past 12 months, BeOne Medicines has paid 111.78M in taxes.
Income Tax111.78M
Effective Tax Rate-0.21
Enterprise Valuation
BeOne Medicines EV to EBITDA ratio is -633.83, with an EV/FCF ratio of -375.16.
EV to Sales65.95
EV to EBITDA-633.83
EV to Free Cash Flow-375.16
EV to Operating Cash Flow-1.79K
Balance Sheet
BeOne Medicines has $2.52B in cash and marketable securities with $996.83M in debt, giving a net cash position of -$1.52B billion.
Cash & Marketable Securities$2.52B
Total Debt$996.83M
Net Cash-$1.52B
Net Cash Per Share-$13.86
Tangible Book Value Per Share$2.34
Margins
Gross margin is -36.09%, with operating margin of -14.91%, and net profit margin of -16.92%.
Gross Margin-36.09%
Operating Margin-14.91%
Pretax Margin-13.99%
Net Profit Margin-16.92%
EBITDA Margin-10.40%
EBIT Margin-14.91%
Analyst Forecast
The average price target for BeOne Medicines is $323.18, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$323.18
Price Target Upside26.40% Upside
Analyst ConsensusStrong Buy
Analyst Count10
Revenue Growth Forecast51.16%
EPS Growth Forecast50.65%